Security Snapshot

2seventy bio, Inc. - Common Stock, par value $0.0001 per share (TSVT) Institutional Ownership

CUSIP: 901384107

13F Institutional Holders and Ownership History from Q4 2021 to Q4 2025

Latest Period

n/a

Institutions Reporting

Shares (Excl. Options)

Price

$5.00

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Security identity 2 facts
Issuer context 3 facts
Shares outstanding
52,406,487
Reported price per share
$5.00
Price from insider filings
$5.00
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Key facts

  • TSVT - 2seventy bio, Inc. - Common Stock, par value $0.0001 per share is tracked under CUSIP 901384107.
  • Latest finished 13F holder period is not available.
  • 2 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 0 to 0 between Q3 2025 and Q4 2025.
  • Reported value moved from $0 to $0.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Schedule 13D/G

Ownership context comes from Schedule 13D/G and available holder history for this CUSIP.

Open SEC Evidence

Security key

901384107

Latest holder period

n/a

13F holders

13D/G owners

2

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
2
Security
TSVT
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
VANGUARD GROUP INC 5.4% $14,069,150 2,819,469 The Vanguard Group 31 Mar 2025
GOLDMAN SACHS GROUP INC 0% $1,531 308 THE GOLDMAN SACHS GROUP, INC. 30 Jun 2025

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
17
Latest
n/a
Rows shown
1-17 of 17
Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 0 $0 -$380,404 $5.00 0
2025 Q3 0 $0 -$507,987 $5.00 0
2025 Q2 95,972 $507,987 -$233,368,571 $9.92 2
2025 Q1 47,343,776 $233,886,428 +$26,350,036 $4.94 135
2024 Q4 45,953,282 $135,099,391 -$4,233,897 $2.94 115
2024 Q3 45,014,292 $212,478,861 -$12,126,215 $4.72 112
2024 Q2 47,616,396 $183,350,210 +$592,537 $3.85 112
2024 Q1 46,621,664 $249,450,311 -$4,585,028 $5.35 112
2023 Q4 48,194,986 $205,771,368 -$19,985,874 $4.27 113
2023 Q3 54,800,462 $214,765,730 -$17,309,644 $3.92 140
2023 Q2 49,877,027 $504,757,759 +$349,413 $10.12 145
2023 Q1 49,797,308 $508,015,188 +$174,343,587 $10.20 140
2022 Q4 32,832,112 $307,624,848 -$28,979,577 $9.37 132
2022 Q3 33,935,762 $493,769,986 -$11,534,913 $14.55 113
2022 Q2 34,631,078 $457,133,912 +$34,811,430 $13.20 115
2022 Q1 31,860,508 $543,474,449 +$220,494,653 $17.06 116
2021 Q4 18,695,153 $479,312,107 +$479,312,107 $25.63 108
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .